EUVIMEDEUVIMED entdecken
Crossref

Management of adenocarcinoma of the pancreatic tail in the elderly

Christina S Boutros, Jonathan J Hue, Mohamedraed Elshami, Luke D Rothermel, Richard S Hoehn, John B Ammori, Jordan M Winter, Lee M Ocuin, Jeffrey M Hardacre

Journal of Surgical Oncology · 2023-03 · 127 (3) · 405-412

DOI: 10.1002/jso.27134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 27.10.2022. Verfasst von Christina S Boutros und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Elderly patients with adenocarcinoma of the pancreatic head can achieve reasonable survival with multimodal therapy. An analysis specific to cancers of the pancreatic tail has not been published.

Methods

We identified patients ≥65 years with localized adenocarcinoma of the pancreatic tail in the National Cancer Database (2011–2017). Patients were grouped by age (65–79 and ≥80 years) and categorized by treatment regimen. Postoperative outcomes and survival were analyzed using propensity score matching and multivariable logistical regression.

Results

2168 patients were included: 73.9% were 65–79 years and 26.1% were ≥80 years. 34.1% of octogenarians did not receive any treatment, relative to 15.9% of younger patients ( p < 0.001). Thirty‐day mortality rates were similar in operatively managed patients; however, the 90‐day mortality rate among octogenarians was greater (3.0% vs. 7.8%, p < 0.001; odds ratio [OR] = 1.85, 95% confidence interval [CI] = 1.07‐3.19). Age ≥ 80 was not associated with survival on multivariable hazards regression (hazard ratio [HR] = 1.08, 95% CI = 0.95–1.24). After propensity matching, the addition of chemotherapy was not associated with improved survival relative to distal pancreatectomy alone among octogenarians (HR = 1.09, 95% CI = 0.72–1.65).

Conclusions

Management of adenocarcinoma of the pancreatic tail varies based on patient age. Resection appears to play a key role in management, but there is substantial upfront risk. Shared decision making should be employed to balance the chance for long‐term survival with the risk of early mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAdenocarcinomaAged, 80 and overHumansAgedPancreasPancreatectomyProportional Hazards ModelsRetrospective StudiesSurvival Rate

Stichwörter der Autor:innen

elderlypancreatic cancersurvival analysis

Autor:innen und Institutionen

  • Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Zitieren

APA

Boutros, C. S., Hue, J. J., Elshami, M., Rothermel, L. D., Hoehn, R. S., Ammori, J. B., Winter, J. M., Ocuin, L. M., & Hardacre, J. M. (2023). Management of adenocarcinoma of the pancreatic tail in the elderly. Journal of Surgical Oncology, 127(3), 405-412. https://doi.org/10.1002/jso.27134

Vancouver

Boutros CS, Hue JJ, Elshami M, Rothermel LD, Hoehn RS, Ammori JB, et al. Management of adenocarcinoma of the pancreatic tail in the elderly. Journal of Surgical Oncology. 2023;127(3):405-412. doi:10.1002/jso.27134

BibTeX
@article{Boutros2023,
  author = {Boutros, Christina S and Hue, Jonathan J and Elshami, Mohamedraed and Rothermel, Luke D and Hoehn, Richard S and Ammori, John B and Winter, Jordan M and Ocuin, Lee M and Hardacre, Jeffrey M},
  title = {Management of adenocarcinoma of the pancreatic tail in the elderly},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  volume = {127},
  number = {3},
  pages = {405--412},
  doi = {10.1002/jso.27134}
}
Kostenlos starten →